Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RG 12915 is a potent, selective 5-HT3 receptor antagonist developed for the treatment of emesis and nausea associated with cancer chemotherapy.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | RG 12915 is a potent, selective 5-HT3 receptor antagonist developed for the treatment of emesis and nausea associated with cancer chemotherapy. |
Molecular Weight | 360.88 |
Formula | C20H25ClN2O2 |
CAS No. | 125363-06-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
RG 12915 125363-06-6 RG12915 Ro 31-7549 Monohydrate Ro-317549 Monohydrate Ro-31-7549 Monohydrate RG-12915 inhibitor inhibit